10.1016/S1262-3636(08)73397-4 67 GerichJ
There are two exceptions that allow a provider to compound a GLP-1 drug: (1) if the drug is not commercially available, and (2) if the compounded drug includes a change, made for an identified individual patient, which produces for that patient a significant difference, as determined by the prescribing practitioner, between the compounded drug and the commercially available product. The identified change must be documented appropriately on the prescription or order
How to Take It: Drink straight or mix into cold water, juice, or a smoothie
( d ) Side view and ( e ) top view of GLP-1R bound to Ex-P5, Chu-128 and Ex-4-D-Alas two conformers shown in cyan, brown, blue, and orange, respectively
Although the specific molecular mechanisms through which obesity promotes carcinogenesis remain not fully elucidated, epidemiological studies indicate that approximately 48% of malignant tumors can be attributed to obesity, and obesity serves as an independent risk factor for poor prognosis in cancer patients [54]